Guest Blogs

Taming the validation dragon

Mon, 27 Oct 2014 13:58:00 GMT

Robert Harrison, pharmaceutical industry manager of COPA-DATA, explains how appropriate technologies can help, rather than hinder, essential regulatory compliance.

Reddy made

Fri, 03 Oct 2014 11:04:00 GMT

Dr. Reddy's Custom Pharmaceutical Services (CPS) explains the integration of highly potent drug substance and drug product manufacturing.

Keep it clean

Tue, 30 Sep 2014 16:06:00 GMT

Andrew Barrow of Cherwell Laboratories offers an insight into monitoring cleanrooms and reducing contamination risk.

Mergers - how do we benefit?

Thu, 25 Sep 2014 12:32:00 GMT

Stephen Archer of Spring Partnerships looks back on months of M&A buzz in the pharma community, and examines whether the industry really stands to benefit from corporate buyouts.

Point of view

Wed, 24 Sep 2014 12:39:00 GMT

Aleksandra Jones outlines the importance of plastics in the production of ready-to-fill syringes

Looking good

Thu, 31 Jul 2014 16:29:49 GMT

It’s important to keep on top of the latest services, companies and individuals. EPM’s Chemical Reaction highlights a technology or business we think would be worth your while keeping in the mix . . .

Liquid assets

Thu, 31 Jul 2014 13:58:00 GMT

Money matters: The most cost-effective way to produce pharmaceuticals is to develop an understanding of the critical phases involved, explains Mark Bosley, Purite.

Talking point

Thu, 31 Jul 2014 13:52:20 GMT

Write stuff: Dave Taylor, Prisym looks at how label lifecycle management systems can improve local language labeling

The whole truth

Thu, 31 Jul 2014 13:45:08 GMT

Safety first: New EU pharmaceutical compliance will tighten up safety within the supply chain and eliminate falsified medicines

Future medicines need new thinking, says RPS

Mon, 07 Jul 2014 18:48:18 GMT

Joint effort: Scientists say a new covenant should be developed between the pharma industry and society

Applying benchtop NMR spectroscopy in the pharma lab

Thu, 15 May 2014 11:28:22 GMT

The latest analytical technology to move to the benchtop is nuclear magnetic resonance (NMR) spectroscopy. High-end, high-cost instrumentation has dominated the NMR sector for many years, with both the initial purchase price and annual running...

Handling pharma recalls — a test of strength for the customer-brand relationship

Thu, 15 May 2014 11:28:08 GMT

Pharmaceutical products and medical devices are among the most highly regulated and most thoroughly tested products in the world. In the UK, the MHRA (Medicines and Healthcare Products Regulatory Agency) is responsible for ensuring that all...

Tracking and authentication — both are important!

Thu, 15 May 2014 11:26:45 GMT

Pharmaceuticals have become one of the most commonly — and most dangerously — counterfeited products, largely because it is so easy for a criminal to make something that looks right but has no — or inadequate — active ingredients. And while this...

Cracking the code on serialisation

Thu, 15 May 2014 11:26:00 GMT

In 2011, the anti-piracy consortium Business Action to Stop Counterfeiting Piracy (BASCAP) of the International Chamber of Commerce estimated that the annual cost of counterfeiting and piracy was $775 billion (£463 billion/€561 billion) and is...

Choosing a lab services partner

Tue, 22 Apr 2014 13:33:00 GMT

In today’s dynamically changing environment, innovation and cost efficiency in drug development is crucial; costs of R&D are growing aggressively with an average investment of $1.3 billion required to successfully initiate a new drug to market...